B · Normal
[Hong Kong Stock IPO: Frontera Therapeutics submits to Hong Kong Stock Exchange] On August 28, Livermore Securities showed that Frontera Therapeutics-B submitted a listing application to the Hong Kong Stock Exchange, and the joint sponsors were UBS Group and Cathay Haitong.
Comments